Evidence-Based Clinical Protocols

Every patient completes a comprehensive health assessment covering medical history, current medications, allergies, and weight loss goals. Our physicians evaluate:

• BMI eligibility: BMI ≥30, or BMI ≥25 with weight-related comorbidities (BMI 25–26.9 is below FDA label and prescribed at provider discretion; BMI under 25 may be considered in cases of abnormal weight gain at provider discretion)
• Contraindication screening: personal or family history of medullary thyroid carcinoma (MTC) or MEN 2
• Drug interaction review: current medications including insulin, sulfonylureas, and oral contraceptives
• Pregnancy and breastfeeding status
• History of pancreatitis, gallbladder disease, or kidney impairment
• Mental health history including eating disorders

If GLP-1 medication isn't appropriate, you won't be charged for the membership.

Your physician selects from five FDA-approved brand-name GLP-1 medications based on your health profile, preferences, and goals:

We never prescribe compounded alternatives. All medications are fulfilled directly by the manufacturer through NovoCare (Novo Nordisk) or LillyDirect (Eli Lilly).

All GLP-1 medications follow a gradual dose escalation (titration) schedule to minimize side effects. Your physician follows manufacturer-recommended titration protocols and adjusts based on your individual response.

• Start at the lowest available dose for 4 weeks
• Gradual dose increases at prescribed intervals
• Physician check-in at every dosage change
• Side effect monitoring with proactive management
• Dosage adjustment or medication switching if needed
• Refill coordination through manufacturer programs
• Unlimited provider messaging between check-ins